Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance.

Carozzi FM, Del Mistro A, Cuschieri K, Frayle H, Sani C, Burroni E.

J Clin Virol. 2016 Mar;76 Suppl 1:S22-S28. doi: 10.1016/j.jcv.2015.10.025. Epub 2015 Nov 10. Review.

PMID:
26669512
2.

VALGENT: A protocol for clinical validation of human papillomavirus assays.

Arbyn M, Depuydt C, Benoy I, Bogers J, Cuschieri K, Schmitt M, Pawlita M, Geraets D, Heard I, Gheit T, Tommasino M, Poljak M, Bonde J, Quint W.

J Clin Virol. 2016 Mar;76 Suppl 1:S14-S21. doi: 10.1016/j.jcv.2015.09.014. Epub 2015 Oct 8. Review.

PMID:
26522865
3.

The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies.

Cubie HA, Moore C, Waller M, Moss S; National Cervical Screening Committee LBC/HPV Pilot Steering Group.

J Clin Virol. 2005 Aug;33(4):287-92.

PMID:
16036178
4.

Commercially available molecular tests for human papillomaviruses (HPV): 2015 update.

Poljak M, Kocjan BJ, Oštrbenk A, Seme K.

J Clin Virol. 2016 Mar;76 Suppl 1:S3-S13. doi: 10.1016/j.jcv.2015.10.023. Epub 2015 Nov 5. Review.

PMID:
26601820
5.

Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.

Poljak M, Oštrbenk A, Seme K, Šterbenc A, Jančar N, Vrtačnik Bokal E.

J Clin Virol. 2016 Mar;76 Suppl 1:S29-S39. doi: 10.1016/j.jcv.2015.11.021. Epub 2015 Nov 19.

PMID:
26643051
6.

Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.

El-Zein M, Richardson L, Franco EL.

J Clin Virol. 2016 Mar;76 Suppl 1:S62-S68. doi: 10.1016/j.jcv.2015.11.020. Epub 2015 Nov 18. Review.

7.

A review of the clinical performance of the Aptima HPV assay.

Haedicke J, Iftner T.

J Clin Virol. 2016 Mar;76 Suppl 1:S40-S48. doi: 10.1016/j.jcv.2015.10.027. Epub 2015 Nov 6. Review.

8.

Implementation of HPV testing in Latin America.

Jeronimo J, Holme F, Slavkovsky R, Camel C.

J Clin Virol. 2016 Mar;76 Suppl 1:S69-S73. doi: 10.1016/j.jcv.2015.11.035. Epub 2015 Nov 28. Review. Erratum in: J Clin Virol. 2017 Oct;95:12.

PMID:
26699418
9.

Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.

Hesselink AT, Sahli R, Berkhof J, Snijders PJ, van der Salm ML, Agard D, Bleeker MC, Heideman DA.

J Clin Virol. 2016 Mar;76:36-9. doi: 10.1016/j.jcv.2016.01.009. Epub 2016 Jan 15.

10.

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.

Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.

11.

HPV testing in the context of post-treatment follow up (test of cure).

Cuschieri K, Bhatia R, Cruickshank M, Hillemanns P, Arbyn M.

J Clin Virol. 2016 Mar;76 Suppl 1:S56-S61. doi: 10.1016/j.jcv.2015.10.008. Epub 2015 Oct 22. Review.

PMID:
26525202
12.

Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers.

Basu P, Banerjee D, Mittal S, Dutta S, Ghosh I, Chowdhury N, Abraham P, Chandna P, Ratnam S.

J Med Virol. 2016 Jul;88(7):1271-8. doi: 10.1002/jmv.24453. Epub 2016 Jan 6.

PMID:
26693677
13.

Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.

Ibáñez R, Moreno-Crespi J, Sardà M, Autonell J, Fibla M, Gutiérrez C, Lloveras B, Alejo M, Català I, Alameda F, Casas M, Bosch FX, de Sanjosé S.

BMC Infect Dis. 2012 Jan 26;12:25. doi: 10.1186/1471-2334-12-25.

14.

[Evaluation of gene chip technology for high risk type human papillomavirus in cervical cancer screening].

Li RZ, Shi JF, Zhou QZ, Wu RF, Li N, Wu LN, Zhou YQ, Wang Q, Liu ZH, Liu B, Qiao YL.

Zhonghua Yi Xue Za Zhi. 2006 Feb 7;86(5):307-11. Chinese.

PMID:
16677522
15.

Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years.

Jayasinghe Y, Rangiah C, Gorelik A, Ogilvie G, Wark JD, Hartley S, Garland SM.

J Clin Virol. 2016 Mar;76 Suppl 1:S74-S80. doi: 10.1016/j.jcv.2015.10.026. Epub 2015 Nov 4.

PMID:
26589584
16.

Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.

Luttmer R, Berkhof J, Dijkstra MG, van Kemenade FJ, Snijders PJ, Heideman DA, Meijer CJ.

J Clin Virol. 2015 Jun;67:59-66. doi: 10.1016/j.jcv.2015.04.004. Epub 2015 Apr 7.

PMID:
25959161
17.

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

Arbyn M, Snijders PJ, Meijer CJ, Berkhof J, Cuschieri K, Kocjan BJ, Poljak M.

Clin Microbiol Infect. 2015 Sep;21(9):817-26. doi: 10.1016/j.cmi.2015.04.015. Epub 2015 May 1. Review.

18.

HPV testing in cervical screening.

Brink AA, Snijders PJ, Meijer CJ, Berkhof J, Verheijen RH.

Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):253-66. Epub 2005 Dec 13. Review.

PMID:
16359926
19.

The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening.

Heideman DA, Hesselink AT, van Kemenade FJ, Iftner T, Berkhof J, Topal F, Agard D, Meijer CJ, Snijders PJ.

J Clin Microbiol. 2013 Nov;51(11):3653-7. doi: 10.1128/JCM.01517-13. Epub 2013 Aug 28.

20.

Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.

Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J; Morelos HPV Study Collaborators.

Salud Publica Mex. 2002 Jul-Aug;44(4):335-44.

PMID:
12216521

Supplemental Content

Support Center